216 related articles for article (PubMed ID: 21114394)
21. Treatment of Clostridium difficile infection.
Gerding DN; Muto CA; Owens RC
Clin Infect Dis; 2008 Jan; 46 Suppl 1():S32-42. PubMed ID: 18177219
[TBL] [Abstract][Full Text] [Related]
22. Fidaxomicin: first-in-class macrocyclic antibiotic.
Mullane KM; Gorbach S
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):767-77. PubMed ID: 21810048
[TBL] [Abstract][Full Text] [Related]
23. Preventing downstream Clostridium difficile infections with upstream antibiotic management.
Malkan AD; Scholand SJ
Med Hypotheses; 2012 Jan; 78(1):136-7. PubMed ID: 22079651
[TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile infections: emerging epidemiology and new treatments.
Cohen MB
J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S63-5. PubMed ID: 19300129
[TBL] [Abstract][Full Text] [Related]
25. A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea.
Wullt M; Odenholt I
J Antimicrob Chemother; 2004 Jul; 54(1):211-6. PubMed ID: 15163651
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure.
Chilton CH; Crowther GS; Freeman J; Todhunter SL; Nicholson S; Longshaw CM; Wilcox MH
J Antimicrob Chemother; 2014 Feb; 69(2):451-62. PubMed ID: 24003182
[TBL] [Abstract][Full Text] [Related]
27. Clostridium difficile: recent epidemiologic findings and advances in therapy.
McMaster-Baxter NL; Musher DM
Pharmacotherapy; 2007 Jul; 27(7):1029-39. PubMed ID: 17594209
[TBL] [Abstract][Full Text] [Related]
28. Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
Ohl ME; Stevermer JJ; Meadows S; Tribuna J; Chek K
J Fam Pract; 2005 Feb; 54(2):176-8. PubMed ID: 15689297
[No Abstract] [Full Text] [Related]
29. Is primary prevention of Clostridium difficile infection possible with specific probiotics?
Johnson S; Maziade PJ; McFarland LV; Trick W; Donskey C; Currie B; Low DE; Goldstein EJ
Int J Infect Dis; 2012 Nov; 16(11):e786-92. PubMed ID: 22863358
[TBL] [Abstract][Full Text] [Related]
30. Fecal bacteriotherapy for recurrent Clostridium difficile infection.
Bakken JS
Anaerobe; 2009 Dec; 15(6):285-9. PubMed ID: 19778623
[TBL] [Abstract][Full Text] [Related]
31. Clostridium difficile disease and vancomycin--questionable clinical superiority.
Tarchini G
Clin Infect Dis; 2011 Jul; 53(2):212. PubMed ID: 21690637
[No Abstract] [Full Text] [Related]
32. Treatment of Clostridium difficile-associated disease.
Leffler DA; Lamont JT
Gastroenterology; 2009 May; 136(6):1899-912. PubMed ID: 19457418
[TBL] [Abstract][Full Text] [Related]
33. Alternative strategies for Clostridium difficile infection.
Bauer MP; van Dissel JT
Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S51-6. PubMed ID: 19303571
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis.
Beinortas T; Burr NE; Wilcox MH; Subramanian V
Lancet Infect Dis; 2018 Sep; 18(9):1035-1044. PubMed ID: 30025913
[TBL] [Abstract][Full Text] [Related]
35. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
Rätsep M; Kõljalg S; Sepp E; Smidt I; Truusalu K; Songisepp E; Stsepetova J; Naaber P; Mikelsaar RH; Mikelsaar M
Anaerobe; 2017 Oct; 47():94-103. PubMed ID: 28465256
[TBL] [Abstract][Full Text] [Related]
36. Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea.
Surawicz CM
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S64-70. PubMed ID: 18545161
[TBL] [Abstract][Full Text] [Related]
37. Limited clinical utility of Clostridium difficile toxin testing in infants in a pediatric hospital.
Tang P; Roscoe M; Richardson SE
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):91-4. PubMed ID: 15964495
[TBL] [Abstract][Full Text] [Related]
38. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol.
Russell G; Kaplan J; Ferraro M; Michelow IC
Pediatrics; 2010 Jul; 126(1):e239-42. PubMed ID: 20547640
[TBL] [Abstract][Full Text] [Related]
39. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
McPherson S; Rees CJ; Ellis R; Soo S; Panter SJ
Dis Colon Rectum; 2006 May; 49(5):640-5. PubMed ID: 16525744
[TBL] [Abstract][Full Text] [Related]
40. Emerging therapies for Clostridium difficile infections.
McFarland LV
Expert Opin Emerg Drugs; 2011 Sep; 16(3):425-39. PubMed ID: 21443387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
